Molekule Group (FRA:9O6) Total Assets : €115.78 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Total Assets?

Molekule Group's Total Assets for the quarter that ended in Jun. 2023 was €115.78 Mil.

During the past 12 months, Molekule Group's average Total Assets Growth Rate was 3071.60% per year.

Total Assets is connected with ROA %. Molekule Group's annualized ROA % for the quarter that ended in Jun. 2023 was -78.19%. Total Assets is also linked to Revenue through Asset Turnover. Molekule Group's Asset Turnover for the quarter that ended in Jun. 2023 was 0.10.

Molekule Group Total Assets Historical Data

The historical data trend for Molekule Group's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group Total Assets Chart

Molekule Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Total Assets

2.63

21.00

27.53

Molekule Group Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Total Assets	Get a 7-Day Free Trial									31.17	29.91	27.53	120.00	115.78

Molekule Group Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Molekule Group's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets	=	Total Equity (A: Dec. 2022 )	+	Total Liabilities (A: Dec. 2022 )
	=	18.6	+	8.926
	=	27.53

Molekule Group's Total Assets for the quarter that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2023 )	+	Total Liabilities (Q: Jun. 2023 )
	=	37.571	+	78.21
	=	115.78

Molekule Group (FRA:9O6) Total Assets Explanation

Total Assets is connected with ROA %.

Molekule Group's annualized ROA % for the quarter that ended in Jun. 2023 is

ROA %	=	Net Income (Q: Jun. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	-92.184	/	( (120.004	+	115.781)	/ 2 )
	=	-92.184	/	117.8925
	=	-78.19 %

Note: The Net Income data used here is four times the quarterly (Jun. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Molekule Group's Asset Turnover for the quarter that ended in Jun. 2023 is

	Asset Turnover
=	Revenue (Q: Jun. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
=	12.223	/	( (120.004	+	115.781)	/ 2 )
=	12.223	/	117.8925
=	0.10

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Molekule Group Total Assets Related Terms

Thank you for viewing the detailed overview of Molekule Group's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Molekule Group (FRA:9O6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (FRA:9O6) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

MKULQ:USA

Address

10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410

Website

https://www.molekule.com

Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.

Molekule Group (FRA:9O6) Headlines

No Headlines